(Q53631405)

English

Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

author name string

Felicetto Ferrara

1

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

Assunta Viola

2

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

Carolina Copia

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

Ettore Mariano Schiavone

4

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

Maria Celentano

5

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

Filiberto Pollio

6

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

Maria Rosaria D'Amico

7

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

Salvatore Palmieri

8

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

publication date

1 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

Hematological Oncology

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

24

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

2

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

73-77

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

The management of adult aggressive non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-Hodgkin lymphoma: an update

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-treatment surveillance of patients with lymphoma treated with curative intent

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups.

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Ifosfamide, epirubicin and etoposide (IEV) regimen as salvage and mobilization therapy for refractory or early relapsing patients with aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis.

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Current treatment options in aggressive lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors associated with survival in patients with progressive disease following autologous transplant for lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival of patients with resistant lymphoma treated with tandem stem cell transplant

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization and outcome of "hard to mobilize"' lymphoma patients undergoing autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose chemotherapy with thiotepa, mitoxantrone and carboplatin (TMJ) followed by autologous stem cell support in 100 consecutive lymphoma patients in a single centre: analysis of efficacy, toxicity and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Pretransplantation Treatment With Rituximab on Outcomes of Autologous Stem-Cell Transplantation for Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonmyeloablative stem cell transplantation for lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.773

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HON.773

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/16550628

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53631405&oldid=1464996810"